Latest research report on “Human Rabies Immunoglobulin (IM) Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5558620
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient’s passive immunization.
In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
This report contains market size and forecasts of Human Rabies Immunoglobulin (IM) in global, including the following market information:
Global Human Rabies Immunoglobulin (IM) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Rabies Immunoglobulin (IM) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Rabies Immunoglobulin (IM) companies in 2021 (%)
The global Human Rabies Immunoglobulin (IM) market was valued at 407.5 million in 2021 and is projected to reach US$ 610 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ERIG Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Rabies Immunoglobulin (IM) include CSL Behring, Grifols, Sanofi, Sichuan Yuanda Shuyang, CNBG, Kamada, CBPO, Shuanglin Bio and Weiguang Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Rabies Immunoglobulin (IM) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Rabies Immunoglobulin (IM) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Immunoglobulin (IM) Market Segment Percentages, by Type, 2021 (%)
– ERIG
– HRIG
Global Human Rabies Immunoglobulin (IM) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Immunoglobulin (IM) Market Segment Percentages, by Application, 2021 (%)
– Category II Exposure
– Category III Exposure
Global Human Rabies Immunoglobulin (IM) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Rabies Immunoglobulin (IM) Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Immunoglobulin (IM) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Rabies Immunoglobulin (IM) revenues share in global market, 2021 (%)
Key companies Human Rabies Immunoglobulin (IM) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Rabies Immunoglobulin (IM) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– CSL Behring
– Grifols
– Sanofi
– Sichuan Yuanda Shuyang
– CNBG
– Kamada
– CBPO
– Shuanglin Bio
– Weiguang Bio
– Shanghai RAAS
– Bharat Serum
– VINS
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5558620
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441